Alifedrine

Alifedrine (INNTooltip International Nonproprietary Name; developmental code name D-13625) is a drug described as a sympathomimetic and cardiotonic or positive inotropic agent which was never marketed.^[3][4][5][6] It is a β-adrenergic receptor partial agonist and was studied in the treatment of heart failure.^[4][1][2][7] The drug is taken by mouth or intravenously.^[1][2] It is a β-hydroxylated substituted amphetamine derivative.^[8]

Other namesD-13625

Routes of
administrationOral, intravenous^[1][2]

Drug classβ-Adrenergic receptor partial agonist; Sympathomimetic

CAS Number

• 78756-61-3 ^Y

Quick facts Clinical data, Other names ...

Alifedrine

Clinical data
Other names	D-13625
Routes of administration	Oral, intravenous[1][2]
Drug class	β-Adrenergic receptor partial agonist; Sympathomimetic
Identifiers
IUPAC name 1-cyclohexyl-3-[[(1R,2S)-1-hydroxy-1-phenylpropan-2-yl]amino]propan-1-one
CAS Number	78756-61-3 Y
PubChem CID	51719
ChemSpider	46808
UNII	K2PM66M0VQ
ChEMBL	ChEMBL2104023
CompTox Dashboard (EPA)	DTXSID00229274
Chemical and physical data
Formula	C18H27NO2
Molar mass	289.419 g·mol−1
3D model (JSmol)	Interactive image
SMILES C[C@@H]([C@@H](C1=CC=CC=C1)O)NCCC(=O)C2CCCCC2
InChI InChI=1S/C18H27NO2/c1-14(18(21)16-10-6-3-7-11-16)19-13-12-17(20)15-8-4-2-5-9-15/h3,6-7,10-11,14-15,18-19,21H,2,4-5,8-9,12-13H2,1H3/t14-,18-/m0/s1 Key:UEELVIXXTBPOCF-KSSFIOAISA-N

Close